nimodipine has been researched along with Diabetes Mellitus, Adult-Onset in 3 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Webb, AJ | 1 |
| Gillies, MJ | 1 |
| Cadoux-Hudson, TA | 1 |
| Hoa, NK | 1 |
| Norberg, A | 1 |
| Sillard, R | 1 |
| Van Phan, D | 1 |
| Thuan, ND | 1 |
| Dzung, DT | 1 |
| Jörnvall, H | 1 |
| Ostenson, CG | 1 |
| Mück, W | 1 |
| Heine, PR | 1 |
| Breuel, HP | 1 |
| Niklaus, H | 1 |
| Horkulak, J | 1 |
| Ahr, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Gynostemma Pentaphyllum Tea Improves Insulin Sensitivity in Type 2 Diabetic Patients[NCT01254084] | Phase 1/Phase 2 | 16 participants (Actual) | Interventional | 2010-02-28 | Completed | ||
| Anti-Diabetic Effect of Gynostemma Pentaphyllum Tea as add-on Therapy With Sulfonylureas in Type 2 Diabetic Patients[NCT00808860] | Phase 1/Phase 2 | 25 participants (Actual) | Interventional | 2008-02-29 | Completed | ||
| Anti-diabetic Effect of Gynostemma Pentaphyllum Tea in Type 2 Diabetic Patients[NCT00786500] | Phase 1/Phase 2 | 24 participants (Actual) | Interventional | 2007-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for nimodipine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
The effect of multiple oral dosing of nimodipine on glibenclamide pharmacodynamics and pharmacokinetics in elderly patients with type-2 diabetes mellitus.
Topics: Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Drug Interactions | 1995 |
2 other studies available for nimodipine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Acute vasospasm following transcallosal resection of a xanthogranulomatous colloid cyst of the 3rd ventricle.
Topics: Angioplasty; Calcium Channel Blockers; Central Nervous System Cysts; Cerebral Angiography; Cerebral | 2010 |
The possible mechanisms by which phanoside stimulates insulin secretion from rat islets.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclic AMP-Dependent Protein Kinases; D | 2007 |
The possible mechanisms by which phanoside stimulates insulin secretion from rat islets.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclic AMP-Dependent Protein Kinases; D | 2007 |
The possible mechanisms by which phanoside stimulates insulin secretion from rat islets.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclic AMP-Dependent Protein Kinases; D | 2007 |
The possible mechanisms by which phanoside stimulates insulin secretion from rat islets.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclic AMP-Dependent Protein Kinases; D | 2007 |
The possible mechanisms by which phanoside stimulates insulin secretion from rat islets.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclic AMP-Dependent Protein Kinases; D | 2007 |
The possible mechanisms by which phanoside stimulates insulin secretion from rat islets.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclic AMP-Dependent Protein Kinases; D | 2007 |
The possible mechanisms by which phanoside stimulates insulin secretion from rat islets.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclic AMP-Dependent Protein Kinases; D | 2007 |
The possible mechanisms by which phanoside stimulates insulin secretion from rat islets.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclic AMP-Dependent Protein Kinases; D | 2007 |
The possible mechanisms by which phanoside stimulates insulin secretion from rat islets.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclic AMP-Dependent Protein Kinases; D | 2007 |